NitroSynapsin for the treatment of neurological manifestations of tuberous sclerosis complex in a rodent model-Reference-Cited by-同舟云学术

NitroSynapsin for the treatment of neurological manifestations of tuberous sclerosis complex in a rodent model

Published:2019-07 Issue: Volume:127 Page:390-397
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Okamoto Shu-ichi,Prikhodko Olga,Pina-Crespo Juan,Adame Anthony,McKercher Scott R.,Brill Laurence M.,Nakanishi Nobuki,Oh Chang-ki,Nakamura Tomohiro,Masliah Eliezer,Lipton Stuart A.

Funder

National Institutes of Health

U.S. Department of Defense

Publisher

Elsevier BV

Subject

Neurology

Reference64 articles.

1. Elevated glucose and oligomeric beta-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation;Akhtar;Nat. Commun.,2016

2. Increased excitation-inhibition ratio stabilizes synapse and circuit excitability in four autism mouse models;Antoine;Neuron,2019

3. Mutations causing syndromic autism define an axis of synaptic pathophysiology;Auerbach;Nature.,2011

4. Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis;Bateup;Neuron.,2013

5. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide;Beckman;Proc. Natl. Acad. Sci. U. S. A.,1990

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Restorative effect of NitroSynapsin on synaptic plasticity in an animal model of depression;Neuropharmacology;2023-12

2. Unveiling new secrets in Parkinson’s disease: The glycatome;Behavioural Brain Research;2023-03

3. Aberrant protein S-nitrosylation contributes to hyperexcitability-induced synaptic damage in Alzheimer’s disease: Mechanistic insights and potential therapies;Frontiers in Neural Circuits;2023-02-02

4. Towards development of disease-modifying therapy for Alzheimer's disease using redox chemical biology pathways;Current Opinion in Pharmacology;2022-10

5. Preliminary Screening of a Familial Tuberous Sclerosis Complex Pathogenic Gene;International Journal of General Medicine;2022-05